Lucijanic, M.; Krecak, I.; Soric, E.; Sabljic, A.; Galusic, D.; Holik, H.; Perisa, V.; Moric Peric, M.; Zekanovic, I.; Budimir, L.;
et al. Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations. Cancers 2025, 17, 1390.
https://doi.org/10.3390/cancers17091390
AMA Style
Lucijanic M, Krecak I, Soric E, Sabljic A, Galusic D, Holik H, Perisa V, Moric Peric M, Zekanovic I, Budimir L,
et al. Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations. Cancers. 2025; 17(9):1390.
https://doi.org/10.3390/cancers17091390
Chicago/Turabian Style
Lucijanic, Marko, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Leonardo Budimir,
and et al. 2025. "Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations" Cancers 17, no. 9: 1390.
https://doi.org/10.3390/cancers17091390
APA Style
Lucijanic, M., Krecak, I., Soric, E., Sabljic, A., Galusic, D., Holik, H., Perisa, V., Moric Peric, M., Zekanovic, I., Budimir, L., & Kusec, R.
(2025). Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations. Cancers, 17(9), 1390.
https://doi.org/10.3390/cancers17091390